Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. Adamec I, Rogic D, Penz MG, Braun C, et al. J Neuroimmunol 2021;362:577788.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Adamec I, Rogic D, Penz MG, Braun C, et al. Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. J Neuroimmunol 2021;362:577788.
PMID: 34922128